Steven Cohen’s Eupraxia Pharmaceuticals EPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-730,284
Closed -$4.83M – 4665
2026
Q2
$4.83M Sell
730,284
-237,291
-25% -$1.64M 0.01% 1787
2026
Q1
$7.01M Buy
967,575
+255,471
+36% +$2.06M 0.01% 1472
2025
Q4
$5.38M Buy
+712,104
New +$4.39M 0.01% 1791

Other funds holding EPRX

Steven Cohen's EPRX Position: Q3 2026 in Review

Steven Cohen sold out of Eupraxia Pharmaceuticals (EPRX) in Q3 2026, closing a stake of 730,284 shares — an estimated $4.83M sold.

Steven Cohen first reported a position in EPRX in Q4 2025 and held it in 3 quarters. The position peaked at $7.01M in Q1 2026. 70 funds tracked by Wall St. Rank hold EPRX as of Q3 2026.

  • Steven Cohen reported no remaining Eupraxia Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
  • Steven Cohen sold 730,284 Eupraxia Pharmaceuticals shares in Q3 2026, an estimated $4.83M.
  • Steven Cohen first reported a position in Eupraxia Pharmaceuticals in Q4 2025 and held it in 3 quarters.
  • Steven Cohen's Eupraxia Pharmaceuticals position peaked at $7.01M in Q1 2026.
  • 70 funds tracked by Wall St. Rank held Eupraxia Pharmaceuticals as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.